Prospective Study of Skipping Meals to Lose Weight as a Predictor of Incident Type 2 Diabetes With Potential Modification by Cardiometabolic Risk Factors: The Canadian 1995 Nova Scotia Health Survey.


Journal

Canadian journal of diabetes
ISSN: 2352-3840
Titre abrégé: Can J Diabetes
Pays: Canada
ID NLM: 101148810

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 15 07 2020
revised: 02 09 2020
accepted: 14 09 2020
pubmed: 22 11 2020
medline: 18 11 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

Skipping meals is an increasingly common practice to lose weight among North American adults. However, the long-term effect of this practice on incident type 2 diabetes mellitus (T2DM) remains unknown. We assessed whether skipping meals to lose weight is associated with T2DM risk and whether this association is modified by cardiometabolic risk factors. Skipping meals to lose weight was assessed by questionnaire in 2,288 adults from the 1995 Nova Scotia Health Survey and was linked to administrative health databases to determine T2DM incidence in the following 23 years. Multivariable-adjusted Cox proportional hazards models estimated hazard ratios (aHRs) and 95% confidence intervals (CIs) for T2DM. During follow up, 378 T2DM cases were diagnosed. Compared with participants who did not skip meals to lose weight, those who did (2.2%) had a 125% higher risk of T2DM (aHR, 2.25; 95% CI, 1.31 to 3.86). This association was no longer present after further adjustment for baseline body mass index (BMI) (aHR, 1.66; 95% CI, 0.96 to 2.85). Skipping meals to lose weight was associated with T2DM among participants who were men (n=1,135; aHR, 2.09; 95% CI, 1.09 to 4.02) or had a BMI <30 kg/m Skipping meals to lose weight may be a predictive modifiable risk factor for developing T2DM over time, potentially working in connection with other T2DM risk factors.

Sections du résumé

BACKGROUND BACKGROUND
Skipping meals is an increasingly common practice to lose weight among North American adults. However, the long-term effect of this practice on incident type 2 diabetes mellitus (T2DM) remains unknown. We assessed whether skipping meals to lose weight is associated with T2DM risk and whether this association is modified by cardiometabolic risk factors.
METHODS METHODS
Skipping meals to lose weight was assessed by questionnaire in 2,288 adults from the 1995 Nova Scotia Health Survey and was linked to administrative health databases to determine T2DM incidence in the following 23 years. Multivariable-adjusted Cox proportional hazards models estimated hazard ratios (aHRs) and 95% confidence intervals (CIs) for T2DM.
RESULTS RESULTS
During follow up, 378 T2DM cases were diagnosed. Compared with participants who did not skip meals to lose weight, those who did (2.2%) had a 125% higher risk of T2DM (aHR, 2.25; 95% CI, 1.31 to 3.86). This association was no longer present after further adjustment for baseline body mass index (BMI) (aHR, 1.66; 95% CI, 0.96 to 2.85). Skipping meals to lose weight was associated with T2DM among participants who were men (n=1,135; aHR, 2.09; 95% CI, 1.09 to 4.02) or had a BMI <30 kg/m
CONCLUSIONS CONCLUSIONS
Skipping meals to lose weight may be a predictive modifiable risk factor for developing T2DM over time, potentially working in connection with other T2DM risk factors.

Identifiants

pubmed: 33218923
pii: S1499-2671(20)30377-4
doi: 10.1016/j.jcjd.2020.09.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-312

Informations de copyright

Copyright © 2020 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Allie S Carew (AS)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Rania A Mekary (RA)

School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences University, Boston, Massachusetts, United States.

Susan Kirkland (S)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Olga Theou (O)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia, Canada.

Ferhan Siddiqi (F)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Robin Urquhart (R)

QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.

Chris Blanchard (C)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Ratika Parkash (R)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Mark Bennett (M)

Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Kerry L Ivey (KL)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Microbiome and Host Health Programme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia; Department of Nutrition and Dietetics, College of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.

Kenneth Mukamal (K)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Department of Medicine, Beth Israel Deaconess Medical Center, Brookline, Massachusetts, United States.

Frank Hu (F)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States.

Eric B Rimm (EB)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States.

Leah E Cahill (LE)

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: leah.cahill@dal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH